Sienna Receives R&D Tax Refund


Sienna Cancer Diagnostics Ltd today announced it has received a $682,921 Research & Development (R&D) Tax Incentive refund for the 2015 financial year.  The R&D Tax Incentive refund relates to Australian R&D expenditure and eligible overseas product development costs. These funds will help support the completion and launch of Sienna’s in-vitro diagnostic (IVD) product which will further expand the company’s available market opportunity.

Sienna Cancer Diagnostics CFO Tony Di Pietro said:

“The receipt of the R&D tax incentive provides important funding to Sienna’s development programs.  This government initiative is an invaluable source of non-dilutive funds for small, innovative Australian companies like Sienna, helping them to launch products into the global market place”.


No Very

Captcha Image

Sign up for updates